BioSpace News Archive

-- Results being presented today in a late-breaking presentation (abstract TH-PO1201) at Kidney Week 2019, the annual meeting of the American Society of Nephrology in Washington, D.C.

AbbVie Inc. announced today that the requisite number of consents have been received to adopt certain proposed amendments with respect to all outstanding notes of certain series issued by Allergan Finance, LLC (“Allergan Finance”), Allergan, Inc. (“Allergan Inc”), Allergan Sales, LLC (“Allergan Sales”) and Allergan Funding SCS

FDA revokes Indivior PLC’s orphan designation for opioid use disorder (OUD)* and prevents an additional five-year block of other monthly buprenorphine depot products for OUD

Cidara Therapeutics, Inc. reported financial results for the three months ended September 30, 2019 and provided an update on its corporate activities and product pipeline.

Agios Pharmaceuticals, Inc. announced that it has priced an underwritten public offering of 8,250,000 shares of common stock at a price to the public of $31.00 per share, before underwriting discounts, which would result in aggregate gross proceeds of approximately $256 million.

Camurus AB today announces that the U.S. Food and Drug Administration has granted Camurus’ US partner Braeburn’s request to revoke orphan drug designation of Sublocade™.

Biotech and pharmaceutical companies from across the globe provide updates on their business and pipelines.

The division previously had three clinical divisions and one nonclinical division. Under the restructuring, it will six divisions, three for oncology.

Through the use of cutting-edge gene sequencing, a team of researchers from Abbott Laboratories discovered a new strain of HIV, the first time a new subtype of HIV-1 has been identified in nearly 20 years.

Enterome and Memorial Sloan Kettering Cancer Center have teamed up to evaluate the potential of gut microbiome-derived antigens for development as potential cancer immunotherapies.